HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Current challenges in liver transplantation for hepatocellular carcinoma.

Abstract
Liver transplantation (LT) is the best option of cure for hepatocellular carcinoma (HCC). Notwithstanding several alternatives, Milan Criteria remain the cornerstone for patient selection. Currently, expanded criteria patients are unsuitable for LT without taking downstaging approaches and response to therapies into consideration. Relative weight of HCC as indication to LT is increasing and that generates competition with MELD-described non-cancer indications. Allocation policies should be adjusted accordingly, considering principles of urgency and utility in the management of the waiting list and including transplant benefit to craft equitable criteria to deal with the limited resource of donated grafts. Maximization of cost-effectiveness of LT in HCC can be also pursued through changes in immunosuppression policies and multimodal management of post-transplant recurrences. This review is focused on those constantly mutating challenges that have to be faced by anyone dealing with the management of HCC in the context of liver transplantation.
AuthorsSherrie Bhoori, Vincenzo Mazzaferro
JournalBest practice & research. Clinical gastroenterology (Best Pract Res Clin Gastroenterol) Vol. 28 Issue 5 Pg. 867-79 (Oct 2014) ISSN: 1532-1916 [Electronic] Netherlands
PMID25260314 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2014 Elsevier Ltd. All rights reserved.
Topics
  • Carcinoma, Hepatocellular (pathology, surgery)
  • Humans
  • Liver Neoplasms (pathology, surgery)
  • Liver Transplantation
  • Patient Selection
  • Resource Allocation
  • Waiting Lists

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: